Background and Aims: Having a body mass index above or equal to 30 kg/m2 in conjunction with chronic hepatitis C virus infection is associated with non-responsiveness to treatment with interferon and ribavirin, but details regarding the mechanisms whereby obesity reduces the efficacy of therapy remain unclear. Methods: This study evaluated impact of obesity on outcome as well as interferon and ribavirin concentrations following standard-of-care fixed dosing with peginterferon-α2a 180 µg once weekly and ribavirin 800 mg daily among 303 HCV genotype 2/3-infected patients enrolled in the per-protocol analysis of a recently completed phase III trial (NORDynamIC). Results: Patients with BMI ≥30 kg/m2 showed poorer outcome following 24 weeks of t...
<div><h3>Background</h3><p>Insulin resistance (IR) is induced by chronic hepatitis C virus (HCV) gen...
Background: Recently, about 2.35% of the world populations are estimated to be chronically infected ...
BACKGROUND & AIMS With the limited efficacy of current therapy for chronic hepatitis C, modifiable...
textabstractBackground and Aims: Having a body mass index above or equal to 30 kg/m2in conjunction w...
in conjunction with chronic hepatitis C virus infection is associated with non-responsiveness to tr...
Background and Aims: Having a body mass index above or equal to 30 kg/m2 in conjunction with chronic...
Background and Aims: Having a body mass index above or equal to 30 kg/m(2) in conjunction with chron...
BACKGROUND/AIMS: Obesity is associated with impaired treatment responses in chronic hepatitis C. The...
The aim of this study was to determine if body mass index (BMI) was an independent predictor of resp...
Original abstract: Background & aims. Chronic hepatitis C is associated with an increased preval...
AbstractObjectiveInfection with hepatitis C virus (HCV) is a serious public health problem worldwide...
Abstract Approximately 80% of patients infected with HCV genotypes 2 or 3 achieve a sustained virolo...
Idült C-vírus-hepatitisben a túlsúly/elhízás a zsírmáj kialakulásának független kóroki tényezője. A ...
Objective: We examined weight changes during chronic hepatitis C (CHC) therapy and association with ...
Objective. To investigate the relationship between insulin resistance and viral load decay in nondia...
<div><h3>Background</h3><p>Insulin resistance (IR) is induced by chronic hepatitis C virus (HCV) gen...
Background: Recently, about 2.35% of the world populations are estimated to be chronically infected ...
BACKGROUND & AIMS With the limited efficacy of current therapy for chronic hepatitis C, modifiable...
textabstractBackground and Aims: Having a body mass index above or equal to 30 kg/m2in conjunction w...
in conjunction with chronic hepatitis C virus infection is associated with non-responsiveness to tr...
Background and Aims: Having a body mass index above or equal to 30 kg/m2 in conjunction with chronic...
Background and Aims: Having a body mass index above or equal to 30 kg/m(2) in conjunction with chron...
BACKGROUND/AIMS: Obesity is associated with impaired treatment responses in chronic hepatitis C. The...
The aim of this study was to determine if body mass index (BMI) was an independent predictor of resp...
Original abstract: Background & aims. Chronic hepatitis C is associated with an increased preval...
AbstractObjectiveInfection with hepatitis C virus (HCV) is a serious public health problem worldwide...
Abstract Approximately 80% of patients infected with HCV genotypes 2 or 3 achieve a sustained virolo...
Idült C-vírus-hepatitisben a túlsúly/elhízás a zsírmáj kialakulásának független kóroki tényezője. A ...
Objective: We examined weight changes during chronic hepatitis C (CHC) therapy and association with ...
Objective. To investigate the relationship between insulin resistance and viral load decay in nondia...
<div><h3>Background</h3><p>Insulin resistance (IR) is induced by chronic hepatitis C virus (HCV) gen...
Background: Recently, about 2.35% of the world populations are estimated to be chronically infected ...
BACKGROUND & AIMS With the limited efficacy of current therapy for chronic hepatitis C, modifiable...